Similarly, hsa-miR-23a-3p seems to enhance tumor and vascular growth in CRC via the Signal Transducer and Activator of Transcription 3/miR-23a-3p/Semaphorin 6D (STAT3/miR-23a-3p/SEMA6D) axis induced by Interleukin-17C (IL-17C), which also leads to VEGF production [13]. The gene discussed is SEMA6D; the disease is neoplasm.